This inventor holds 1 USPTO granted patent. Top assignee: Oxford University Innovation Ltd. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: The Innovations of Ricky Cain
Introduction
Ricky Cain is an accomplished inventor based in Oxford, GB. He has made significant contributions to the field of medicine, particularly in the development of β-lactamase inhibitors. His work focuses on enhancing the effectiveness of antibiotics in treating tuberculosis and other infections.
Latest Patents
Ricky Cain holds 1 patent for his invention related to β-lactamase inhibitors. This patent outlines the use of specific inhibitors in conjunction with β-lactam antibiotics, aiming to improve treatment outcomes for patients suffering from tuberculosis and various infections.
Career Highlights
Ricky Cain is associated with Oxford University Innovation Ltd, where he continues to advance his research and innovations. His work has garnered attention for its potential impact on public health and antibiotic resistance.
Collaborations
Ricky has collaborated with notable colleagues, including Samuel T Cahill and James Spencer. These partnerships have contributed to the development and refinement of his innovative approaches in the medical field.
Conclusion
Ricky Cain's contributions to the field of medicine through his patent on β-lactamase inhibitors highlight his commitment to improving treatment options for infectious diseases. His work exemplifies the importance of innovation in addressing global health challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile